Home › Funds › Vestal Point Capital, LP › UTHR
Vestal Point Capital, LP position in UTHR
UNITED THERAPEUTICS CORP DEL · Health Care
Vestal Point Capital, LP reported holding 435,000 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q2 2026 13F filing — a position valued at US$235.7M, representing 5.51% of its reported portfolio and ranking #4 among its reported holdings. Vestal Point Capital, LP has disclosed UTHR holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Vestal Point Capital, LP's UTHR position evolved
Vestal Point Capital, LP first disclosed a stake in UTHR in Q1 2026 at 75,000 shares (US$44.5M). The position peaked in Q2 2026 at 435,000 shares, worth US$235.7M. Across 2 filings, Vestal Point Capital, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 435,000 shares valued at US$235.7M — an increase of 360,000 shares quarter over quarter.. Notable position changes include a 480% increase in Q2 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 75.00K | $44.47M | New |
| Q2 2026 | 435.00K | $235.70M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About UTHR and 13F data
UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 42 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$925.8M), ASSETMARK, INC (US$338.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding UTHR
- Avoro Capital Advisors LLC 2.78M sh · $1.51B · Q2 2026
- Renaissance Technologies 1.71M sh · $925.85M · Q2 2026
- ASSETMARK, INC 624.07K sh · $338.14M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 457.00K sh · $247.62M · Q2 2026
- Eversept Partners, LP 287.67K sh · $155.87M · Q2 2026
More on Vestal Point Capital, LP
FAQ
How long has Vestal Point Capital, LP held UTHR?
Vestal Point Capital, LP has disclosed UTHR holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Vestal Point Capital, LP's current position in UTHR?
As of Q2 2026, Vestal Point Capital, LP holds 435.00K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $235.70M, representing 5.51% of its reported portfolio and ranking #4.
Has Vestal Point Capital, LP been buying or selling UTHR?
In the latest 13F filing (Q2 2026), Vestal Point Capital, LP increased its position in UTHR. The position peaked in Q2 2026 at 435.00K shares.
Which other funds hold UTHR?
Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.